FDA to reconsider decision barring compounded versions of Lilly weight loss drug
The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...
FDA approves first once-weekly drug treatment regimen for hemophilia
Patients suffering from hemophilia received a "meaningful" advancement on Friday when federal regulators approved the first ...
US FDA approves Pfizer's drug for rare bleeding disorder
The U.S. Food and Drug Administration approved Pfizer's once-a-week injection for the two main types of a rare bleeding ...
CNET4h
12 Fruits and Vegetables to Wash Before Eating
It's true that veggies can be some of the healthiest foods you put on your plate but some have higher instances of pesticides ...
Washington AG, 17 others push FDA to loosen restrictions on abortion drug
Washington is leading a coalition of 18 attorneys general who are pushing the Food and Drug Administration to ease ...
Boise State Public Radio12h
Manufacturers and feds work to stabilize supply of IV fluids for hospitals
After Hurricane Helene flooded an IV fluid factory in North Carolina, the government and industry are trying to mitigate ...
Drug makers can’t make knockoff weight-loss drugs anymore—and they’re mad
With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to ...
Why Ozempic, Zepbound, and other weight-loss drug dupes carry risks
Poor purity can cause patients to experience fever, chills, nausea, skin irritation, infections and low blood pressure.
FDA approves Genentech drug aimed at subset of breast cancer patients
Itovebi — also known as inavolisib — is designed to be given with drugs from Pfizer Inc. and AstraZeneca plc to treat adults ...
devdiscourse42m
FDA Reconsiders Restrictions on Drug Compounders
The FDA has decided to reconsider its ban on drug compounders from making versions of Eli Lilly's weight loss and diabetes ...
U.S. Food and Drug Administration (FDA) accepts New Drug Application for elinzanetant
Bayer today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s New Drug Application (NDA) ...
aha.org1h
FDA Issues Guidance for Compounding Certain Drug Products in Response to IV Solutions Supply Disruption
The Food and Drug Administration (FDA) today released guidance that is effective immediately for compounding certain parenteral drug products in response to the effects of recent hurricanes, including ...